At a Glance
Dosage
oral
| Level | ALD-52 | DOI |
|---|---|---|
| Threshold | 30 µg | 0.5 mg |
| Light | 30–100 µg | 0.5–1 mg |
| Common | 100–175 µg | 1–2 mg |
| Strong | 175–325 µg | 2–3 mg |
| Heavy | 325 µg | 3 mg |
Duration
oral
ALD-52
oral
Total: 8 hrs – 14 hrsPeak
Offset
Afterglow
Onset20 min – 40 min
Come Up1 hrs – 2 hrs
Peak3 hrs – 5 hrs
Offset
Effects
Safety
Interaction: ALD-52 + DOI
No direct interaction data available between these substances. This does not mean the combination is safe.
ALD-52 — Dangerous Interactions
No dangerous interactions recorded.
DOI — Dangerous Interactions
No dangerous interactions recorded.
Frequently Asked Questions
What is the difference between ALD-52 and DOI?
ALD-52 is classified as a Psychedelic (Lysergamides) while DOI is classified as a Psychedelic (Substituted amphetamines). They share 54 effects in common, with 17 effects unique to ALD-52 and 12 unique to DOI.
Is it safe to combine ALD-52 and DOI?
There is no direct interaction data available for combining ALD-52 and DOI. This does not mean the combination is safe. Always exercise caution and research thoroughly.
Which is stronger, ALD-52 or DOI?
At common doses via oral, ALD-52 is typically dosed at 100–175 µg while DOI is dosed at 1–2 mg. However, "stronger" depends on context — potency, subjective intensity, and duration all factor in. These substances have different pharmacological profiles and comparing raw potency is not straightforward.